Results 201 to 210 of about 2,961,047 (262)

Assessment of the hospital pharmacy quality assurance system in selected hospitals in the Amhara Regional State, Ethiopia. [PDF]

SAGE Open Med
Anagaw YK, Feleke MG, Mekuriaw ET, Mitku ML, Limenh LW, Bayleyegn ZW, Worku MC, Denekew T, Geremew DT, Ayenew W.   +9 more
europepmc   +1 more source

A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau

Advanced Science, EarlyView.
TP2 is a fully synthetic small‐molecule dephosphorylation‐targeting chimera that recruits endogenous PP2A‐Bα to Tau, enabling targeted removal of pathological phosphate modifications. In two tauopathy mouse models, systemic TP2 reduces Tau pathology, preserves neuronal and synaptic integrity, improves neuroimmune homeostasis, and rescues cognition ...
Fei Sun, Yang Liu, Qiuzhi Zhou, Qingyuan Hu, Weixia Wang, Yue Xiao, Jingfen Su, Guanting Liu, Miaomiao Sun, Lixia Chen, Hua Li, Ying Yang, Jian‐Zhi Wang   +12 more
wiley   +1 more source

Canadian Hospital Pharmacy Residency Graduates/Diplômés De Programmes Canadiens De Résidence En Pharmacie Hôpitalière. [PDF]

Can J Hosp Pharm
europepmc   +2 more sources

Hospital pharmacy implementation of a unit dose dispensing system: A qualitative interview study to determine experiences, views and attitudes of nursing staff. [PDF]

Explor Res Clin Soc Pharm
Steindl-Schönhuber T, Drechsel T, Gittler G, Weidmann AE.   +3 more
europepmc   +1 more source

Kidney‐Targeted Cilastatin Nanoparticles Inhibit DPEP1‐Mediated Ferroptosis for Acute Kidney Injury Therapy

Advanced Science, EarlyView.
In this study, MPDA NPs were engineered to encapsulate CTT. To further increase renal accumulation of CTT, L‐serine was conjugated to the surface of the MPDA nanoparticles (CTT/MPDA@L‐Ser NPs). CTT/MPDA@L‐Ser NPs inhibit DPEP1 activity, thereby restoring ferroptosis defense mechanisms through upregulation of GPX4 and SLC7A11 expression, ultimately ...
Wanbing Qin, Jiaqi Huang, Manting Zhang, Wanchun Yang, Mingwei Xu, Chi Jiang, Jiekai Li, Jinjuan Wen, Qibin Huang, Shiqi Wen, Weidong Wang, Junbing He, Qinghua Liu   +12 more
wiley   +1 more source

A New Era for the Canadian Journal of Hospital Pharmacy: The Continuous Publication Model. [PDF]

Can J Hosp Pharm
Shalansky S.
europepmc   +1 more source

Programmable Paracrine‐Mimetic Microneedle System for Temporal Regulation of Cardiac Repair

Advanced Science, EarlyView.
Temporal signaling is encoded into a programmable paracrine‐mimetic microneedle patch via tris(2,2'‐bipyridyl)dichlororuthenium(II) hexahydrate/sodium persulfate‐tuned hydrogel microparticles that deliver TGF‐β, IGF‐1, and VEGF over phase‐matched 7‐, 14‐, and 28‐day windows.
Yichen Dai, Pengchong Du, Zhaoyang Wang, Surilige, Rangga Fokta, Renjian Tan, Xiqing Zhao, Shuoyi Zhang, Yuecheng Wang, Yixin Zhang, Ziliang Fu, Rui Gong, Cheng Jiang, Yisheng He, Qiguang Wang, Renke Li, Khoon Lim, Junnan Tang, Xiaolin Cui   +18 more
wiley   +1 more source

A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging. [PDF]

Ther Adv Drug Saf
Bello W, Pezzatti J, Stampfli C, Carrez L, Rudaz S, Sadeghipour F.   +5 more
europepmc   +1 more source

Impacts of a multipurpose outpatient hospital pharmacy in the framework of 3P medicine. [PDF]

EPMA J
González Freire L, Veiga Villaverde AB, Ballester Vieitez A, Olivera Fernández R, Crespo-Diz C.   +4 more
europepmc   +1 more source

Piloting a Hospital Pharmacy Performance Model in the Face of Province-Wide Implementation of Activity-Based Funding in Quebec Health Care Centres. [PDF]

Can J Hosp Pharm
Boucher F, Schryve S, Bonnici A, Desparois C, Paradis F, Racicot J, Vo D, Lemire B, Vaillant L.   +8 more
europepmc   +1 more source